Latest Articles

Emerging medical device companies should consider these points when weighing a potential merger, strategic partnership or investment:1. Identify unmet medical needs Medical device titans are actively looking to acquire new technologies to treat unmet medical needs and drive market adoption. Larger medtech companies often view early-stage companies as outsourced R&D labs, and will pay a premium price for products that can drive future revenue. The larger the potential market, the higher the value to medtech titans.…
The Boston office of Greenberg Traurig LLP is hosting a breakfast program featuring Prof. Eran Segal of Israel’s Weizmann Institute of Science. The program, The Next Nutritional Revolution: Scientifically Tailored Diets, is Friday, Sept. 19, 2014, and begins at 7:45 a.m. with networking and a light breakfast. Prof. Segal will speak at 8:15 a.m. Individuals interested in attending should RSVP to Rachel Sievers at rachesl@acwis.org or 212.895.7904.…
This Wednesday, April 24, the New England Israel Business Council (NEIBC) is presenting “Trends & Challenges in the Israeli Med-Tech Arena” breakfast seminar on this Wednesday, April 24 from 8:30 – 10:00 am at Greenberg Traurig, One International Place in Boston. The featured speaker is Elka Nir, Managing Director, Life Sciences at Giza Venture Capital. Greenberg Traurig is sponsoring the event which is free to attend. GT Patent Attorneys David Dykeman and Roman Fayerberg will…